Literature DB >> 9636479

Therapeutic drug monitoring of mycophenolic acid: comparison of HPLC and immunoassay reveals new MPA metabolites.

E Schütz1, M Shipkova, V W Armstrong, P D Niedmann, L Weber, B Tönshoff, K Pethig, T Wahlers, F Braun, B Ringe, M Oellerich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9636479     DOI： 10.1016/s0041-1345(98)00201-2

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  16 in total

Review 1.  Therapeutic drug monitoring of immunosuppressant drugs.

Authors:  A Johnston; D W Holt
Journal:  Br J Clin Pharmacol       Date:  1999-04       Impact factor: 4.335

Review 2.  Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

3.  Unexpectedly high exposure to enteric-coated mycophenolate sodium upon once-daily dosing.

Authors:  Guido Filler; Anita Lathia; Claire LeBlanc; Uwe Christians
Journal:  Pediatr Nephrol       Date:  2006-05-24       Impact factor: 3.714

4.  Pharmacokinetics of mycophenolate mofetil for autoimmune disease in children.

Authors:  Guido Filler; Miriam Hansen; Claire LeBlanc; Nathalie Lepage; Doris Franke; Ingrid Mai; Janusz Feber
Journal:  Pediatr Nephrol       Date:  2003-04-08       Impact factor: 3.714

5.  Identification of glucoside and carboxyl-linked glucuronide conjugates of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil.

Authors:  M Shipkova; V W Armstrong; E Wieland; P D Niedmann; E Schütz; G Brenner-Weiss; M Voihsel; F Braun; M Oellerich
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

Review 6.  Therapeutic monitoring of mycophenolate mofetil in organ transplant recipients: is it necessary?

Authors:  Michel Mourad; Pierre Wallemacq; Josiane König; Evelyne Henry de Frahan; Djamila Chaib Eddour; Martine De Meyer; Jacques Malaise; Jean Paul Squifflet
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 7.  To what extent does the understanding of pharmacokinetics of mycophenolate mofetil influence its prescription.

Authors:  Guido Filler; Nathalie Lepage
Journal:  Pediatr Nephrol       Date:  2004-07-15       Impact factor: 3.714

8.  Performance of the new mycophenolate assay based on IMPDH enzymatic activity for pharmacokinetic investigations and setup of Bayesian estimators in different populations of allograft recipients.

Authors:  Pierre Marquet; Franck Saint-Marcoux; Aurélie Prémaud; François-Ludovic Sauvage; Evelyne Jaqz-Aigrain; Christiane Knoop; Yvon Lebranchu; Marco Tiberi; Ingrid Domke; Jean Debord
Journal:  Ther Drug Monit       Date:  2009-08       Impact factor: 3.681

Review 9.  Coronary artery vasculopathy in pediatric cardiac transplant patients: the therapeutic potential of immunomodulators.

Authors:  Biagio Pietra; Mark Boucek
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

10.  Random pharmacokinetic profiles of EC-MPS in children with autoimmune disease.

Authors:  Guido Filler; Ajay Parkash Sharma; Deborah M Levy; Abeer Yasin
Journal:  Pediatr Rheumatol Online J       Date:  2010-01-04       Impact factor: 3.054
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.